Insilica
Bethesda
About Insilica
Insilica builds machine learning into medicine, chemistry and knowledge creation and to accelerate human learning, and collaboration. They are building informatics into public health, medicine, and chemistry Products include: Sysrev - a modern take on document review BioBricks - managed public-health data assets ToxIndex - searchable chemical knowledgebase
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $2.3M
- Last round: Grant (May 2025)
- Website: insilica.co
- Phone: [email protected]
Industries & Categories
Information Technology, Machine Learning
Social Profiles
Canonical: https://fsome.com/organization/insilica-41256 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.